SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of October, 2025
(Commission File No. 1-14862 )
BRASKEM S.A.
(Exact Name as Specified in its Charter)
N/A
(Translation of registrant's name into English)
Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil
(Address of principal executive offices)
Indicate by check mark whether the registrant
files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ___X___ Form 40-F ______
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____
Indicate by check mark if the registrant is
submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____
Indicate by check mark whether the
registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant
to Rule 12g3-2(b) under the Securities Exchange Act of 1934.
Yes ______ No ___X___
If "Yes" is marked, indicate below
the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.
BRASKEM S.A.
National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70
State Registration (NIRE) 29300006939
A Publicly Held Company
MANAGEMENT PROPOSAL
FOR THE EXTRAORDINARY GENERAL MEETING OF BRASKEM S.A.
TO BE HELD ON NOVEMBER 13, 2025
Dear Shareholders,
The Management of Braskem S.A. (“Company”
or “Braskem’”) hereby submits a proposal (“Proposal”) in relation to the matters contained
in the agenda of Braskem’s Extraordinary General Meeting, to be held on November 13, 2025, at 3:00 p.m., in an exclusively digital
manner, pursuant to article 5, paragraph 2, item I, and article 28, paragraphs 1, 2 and 3 of Brazilian Securities Commission (“CVM”)
Resolution No. 81, of March 29, 2022 (“CVM Resolution 81”), through digital platform Webex (“Digital Platform”
and “Meeting”, respectively)).
The Company clarifies that, pursuant to article 9, sole paragraph,
of the Bylaws, Class “A” and “B” preferred shares shall be entitled to vote at this Meeting and shall vote jointly
with the common shares on the resolutions regarding the matters on the Agenda.
1.
Replacement of one (1) effective member of the Company’s
Board of Directors appointed by Novonor S.A. – Under Judicial Reorganization (“Novonor”) and by NSP Investimentos S.A.
– Under Judicial Reorganization (“NSP Inv.”), to complete the remaining term of office, until the Annual General Meeting
that will resolve on the Company’s financial statements for the fiscal year ending on December 31, 2025
Considering the resignation submitted by Mr. Roberto Faldini from
his position as an Effective Member of the Company’s Board of Directors, the Company’s Management submits to the shareholders
the resolution on the election, as indicated by Novonor and NSP Inv. pursuant to Item 3.2.2 (a) of Braskem’s Shareholders’
Agreement, of Mr. Lucas Cive Barbosa as an Effective Member of the Company’s Board of Directors, replacing Mr. Roberto Faldini,
who was also appointed by Novonor and NSP Inv. The effective member will be elected to complete the current term, which will end at the
Annual General Meeting that will review the financial statements for the fiscal year ending December 31, 2025 (“AGM 2026”).
Annex I to this Proposal contains information about the
candidate for Effective Member of the Board of Directors (“BoD”) nominated by shareholders Novonor and NSP Inv., as
well as his professional experience, pursuant to items 7.3 to 7.6 of the Reference Form, in compliance with Article 11, item I, of CVM
Resolution 81.
Impossibility of Separate Election or Multiple Vote
In line with the understanding of the CVM Board, considering that
the Meeting is being convened for the replacement of one (1) effective member of the Company’s Board of Directors, elected by majority
vote, there will be no possibility of adopting separate election, as provided for in paragraphs 4 and 5 of Article 141 of Law No. 6,404
of December 15, 1976 (“Brazilian Corporations Law”), nor will multiple vote be applicable.
2.
Amendment to article 2 of the Company's Bylaws, to improve its wording
by aligning the description of the corporate purpose with the current reality of the activities performed by the Company
The Management of the Company proposes to the Shareholders
the resolution regarding the amendment of article 2 of the Company's Bylaws, in order to improve its wording, adapting the text of the
corporate purpose to the current reality of the activities carried out by the Company, as justified in detail in the comparative table
included in Annex II of this proposal, pursuant to article 12, item II of CVM Resolution 81.
It is emphasized that the adjustments to the Company's corporate
purpose do not constitute a change in the corporate purpose for the purposes of article 137 in conjunction with article 136 of the Brazilian
Corporations Law.
A copy of the Company’s Bylaws, highlighting the proposed
amendments, pursuant to article 12, item I of CVM Resolution 81, is included in Annex III of this Proposal.
3.
Inclusion of a provision in the Company's Bylaws to detail the
rules and procedures for the election of the Board of Directors
The Company’s Management proposes to the Shareholders
the resolution regarding the inclusion of a new article 20 in the Company’s Bylaws, with the purpose of improving the rules and
the structure of the process for electing the Board of Directors at the General Shareholders’ Meeting, providing greater transparency
to the election process, as detailed in the comparative table included in Annex II of this Proposal, pursuant to article 12, item
II of CVM Resolution 81.
A copy of the Company’s Bylaws, highlighting the proposed
amendments, pursuant to article 12, item I of CVM Resolution 81, is included in Annex III of this Proposal.
4.
Amendment to article 26 of the Company's Bylaws to: (a) update
the approval thresholds of the Board of Directors; (b) authorize the Board of Directors to decide on the maintenance or monetary adjustment
of such thresholds; and (c) remove from the Board of Directors’ responsibilities the selection and replacement of the independent
auditors of the subsidiaries
The Company’s Management proposes to the Shareholders
the amendment of article 26 of the Company’s Bylaws to:
| (a) | update the approval thresholds of the Board
of Directors in accordance with inflation (IPCA) for the period, calculated from the date of approval of each threshold; |
| (b) | include a provision granting the Board of
Directors specific authority to annually assess the appropriateness of updating the approval thresholds under its responsibility, based
on inflation variation measured by officially recognized inflation indices; and |
| (c) | remove from the list of responsibilities
of the Board of Directors the authority to appoint and replace the independent auditors of the Company’s subsidiaries, allowing
the Executive Board to have autonomy over this matter, while enabling the Board of Directors to focus on strategic issues. |
The origin and justification of the proposed amendments, as
well as the marked-up version of the provisions of the Company’s Bylaws with the proposed changes, pursuant to article 12, item
II of CVM Resolution 81, are detailed in the comparative table included in Annex II of this Proposal. Additionally, a copy of the
Company’s Bylaws highlighting the proposed amendments, pursuant to article 12, item I of CVM Resolution 81, is included in Annex
III of this Proposal.
5.
Due to the amendments resolved in items 2 to 4 above, resolve on the
consolidation of the Company's Bylaws, including the renumbering of articles and paragraphs as applicable
The Company’s Management proposes to the Shareholders,
in light of the amendments resolved above, to resolve on the consolidation of the Company’s Bylaws, including the renumbering of
articles and paragraphs, as applicable.
A copy of the Company’s Bylaws, highlighting the proposed
amendments, pursuant to article 12, item I of CVM Resolution 81, is included in Annex III of this Proposal.
Shareholders’ Participation:
The Meeting will be held exclusively digitally, for which
reason the Shareholder's participation can only be:
(a) via
remote voting ballot (“Ballot”), with detailed instructions regarding the documentation required for remote voting provided
in the Ballot and in the Manual for Shareholder’s Participation, which can be accessed on the Company website (www.braskem-ri.com.br),
CVM website (www.cvm.gov.br) and B3 website (www.b3.com.br);
and
(b) via Digital Platform, in person or
through an attorney-in-fact duly appointed pursuant to article 28, paragraphs 2 and 3 of CVM Resolution 81, in which case the Shareholders
may: (i) simply take part in the Meeting, whether
or not they have sent the Ballot; or (ii) participate and vote at the Meeting, noting that, for the Shareholders who have already sent
the Ballot and wish to vote at the Meeting, all voting instructions received by Ballot will be disregarded.
The Braskem’s Extraordinary General Meeting will be
held exclusively in a digital format, considering that, in the judgment of the Management, this format reduces Shareholder participation
costs, facilitates and contributes to greater attendance from the Company's shareholder base at the Meeting, thus increasing the representativeness
of the resolutions to be taken.
Documents necessary to access the Digital Platform:
The Shareholders that wish to take part in the Meeting must
send to e-mail address braskem-ri@braskem.com, with a request for receipt confirmation, at
least two (2) days in advance of the date scheduled for the Meeting, that is, by November 11, 2025, the following documents:
| (i) | evidence issued by the financial institution
depositary of the book-entry shares held thereby, proving ownership of the shares at least eight (8) days prior to the Meeting; |
| (ii) | if the Shareholder is (a) an individual,
the Shareholder’s identity document; or (b) legal entity, instrument of incorporation, bylaws or articles of incorporation, minutes
of election of the Board of Directors (if any) and minutes of election of the Executive Office that prove the powers of representation; |
| (iii) | if the Shareholder is an investment fund,
the fund rules with the information referred to above, pertaining to its administrator or manager, according to the representation rules
foreseen in the fund’s regulation; |
| (iv) | additionally, in case the Shareholder (individual,
legal entity or investment fund) is represented by an attorney-in-fact, (i) the respective power of attorney, granted in compliance with
article 126, paragraph 1, of the Brazilian Corporations Law; and (b) identity document of the attorney-in-fact; and |
| (v) | with respect to Shareholders participating
in the fungible custody of registered shares, a statement with the respective equity interest, issued by the entity with authority. |
Pursuant to article 6, paragraph 3, of CVM Resolution 81,
access to the Digital Platform shall be forbidden to Shareholders that do not submit the necessary participation documents within the
deadline set forth herein.
The Company explains that it shall waive the sending of the
physical counterparts of the Shareholders’ representation documents to the Company’s offices, as well as the authenticity
certification of the grantor’s signature on the power of attorney for representation of the Shareholder, the notarization, the consularization,
the annotation and the sworn translation of all of the Shareholder’s representation documents, sufficing to send a simple copy of
the original counterparts of said documents to the Company’s e-mail stated above.
The Company does not accept powers of attorney granted by
Shareholders through electronic means (i.e., digitally signed powers of attorney without any digital certification).
Below we describe detailed information about the deadlines
and procedures for participating in the Meeting:
(a) via remote
voting ballot: The Company will adopt the remote voting in accordance with CVM Resolution 81, allowing its Shareholders to submit
their votes up to 4 (four) days prior to the date scheduled for the Meeting, that is, until November 09, 2025:
(i) through their respective custody agents or through the central depository;
(ii) through the Company’s shares registrar (Itaú Corretora de Valores S.A.), located at Avenida Brigadeiro Faria Lima,
No. 3,500, 3rd floor, São Paulo, ZIP Code 04538-132, with shareholder support available at the phone numbers 3003-9285 (for capitals
and metropolitan regions) or 0800 720 9285 (other locations through the website https://assembleiadigital.certificadodigital.com/itausecuritiesservices/artigo/atendimento/perguntas-frequentes
or email PreAtendimentoEscritural@itau-unibanco.com.br); or
(iii) directly to the Company:
(iii.1) by physical delivery, by sending to the office located at Rua Lemos Monteiro, No. 120, 24th floor, City of São Paulo,
State of São Paulo, ZIP Code 05501-050; or
(iii.2) by electronic means, to the email braskem-ri@braskem.com, with a receipt confirmation
request, as per the instructions contained in the Ballot itself.
(b) via Digital
Platform: the Shareholders that wish to take part in the Meeting must send the request to the Company through e-mail braskem-ri@braskem.com,
with a request for receipt confirmation, at least two (2) days in advance of the date set for the Meeting to be held, that is, by
November 11, 2025, which must also be properly accompanied by all of the Shareholder’s documents for participation in the Meeting
(as detailed above, in the Call Notice and in the Manual to Participate in the Meeting), noting that access to the Digital Platform
shall be forbidden for shareholders that do not submit the necessary participation documents within the deadline set herein, pursuant
to article 6, paragraph 3, of CVM Resolution 81.
The Company shall send, through the Digital Platform, individual
invitations to access the said Digital Platform and the respective access instructions to the Shareholders who have submitted their
request within the deadline and under the conditions mentioned
above, as already set forth in the Manual for Participation in the Meeting.
The Shareholder who participates through the Digital Platform
or whose remote voting ballot has been deemed valid by the Company shall be considered present at the Meeting, entitled to exercise their
respective voting rights, and a signatory of the respective Minutes of the Meeting, pursuant to article 47, paragraph 1 of CVM Resolution
81.
If the Shareholder that has properly requested to participate
does not receive from the Company the email with instructions for access and participation in the Meeting at least 24 hours prior to its
scheduled time (i.e., by 3:00 p.m. on November 12, 2025), they must contact the Company by phone at +55 (11) 3576-9531 —
in any event, before 1:00 p.m. on November 13, 2025, so that the respective access instructions may be resent (or provided over
the phone).
The Company shall provide technical support in case the Shareholders
have any problems participating in the Meeting. However, the Company takes no responsibility for any operational or connection issues
the Shareholder may face, nor for any other possible matters not related to the Company, which may hinder or prevent the Shareholder from
participating in and voting at the Meeting.
The Company also recommends that the Shareholders become familiar
with the use thereof beforehand, as well as that they ensure the compatibility of their electronic devices with the use of the platform
(by video and audio).
Additionally, the Company asks the Shareholders to, on the
day of the Meeting, access the Webex Digital Platform at least 15 (fifteen) minutes before the time scheduled for the Meeting to start,
to enable access validation and participation of all Shareholders using it.
Finally, all the exhibits are detailed in this Proposal in
accordance with the laws and regulations.
The Management
* * *
ANEXO |
PÁGINA |
ANNEX I – Information about the candidate nominated by shareholders Novonor and NSP Inv. to serve as an effective member of the Company’s Board of Directors (items 7.3 to 7.6 of the Reference Form), pursuant to Article 11, item I of CVM Resolution 81. |
8 |
ANNEX II – Report detailing the origin and justification of the proposed amendments to the Company's Bylaws and analyzing their legal and economic effects, presented in table format, pursuant to Article 12, item II of CVM Resolution 81. |
14 |
ANEXO III – Copy of the Company's Bylaws with the proposed amendments clearly highlighted, pursuant to Article 12, item I of CVM Resolution 81. |
23 |
BRASKEM S.A.
National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70
State Registration (NIRE) 29300006939
A Publicly Held Company
MANAGEMENT PROPOSAL
FOR THE EXTRAORDINARY GENERAL MEETING OF BRASKEM S.A.
TO BE HELD ON NOVEMBER 13, 2025
ANNEX I
Information about the candidate
nominated by shareholders Novonor and NSP Inv. to serve as an effective member of the Company’s Board of Directors (items 7.3 to
7.6 of the Reference Form), pursuant to Article 11, item I of CVM Resolution 81.
7.3. In relation to each of the managers and members of the
issuer's fiscal council, indicate:
Name |
Management Body |
Effective Office Held |
Date of Election |
Date of Investiture |
Lucas Cive Barbosa 1 |
Board of Directors |
Board Member (Effective) |
11/13/2025 |
11/13/2025 |
Nationality |
Individual Taxpayer Registry (Cadastro de Pessoas Físicas – CPF) |
Termo of Office |
Start of 1st Term |
Elected by the controlling shareholder? |
No. of Passport |
|
Brazilian |
323.198.758-08 |
Until AGO 2026 |
11/13/2025 |
Yes |
N/A |
|
1 Mr.
Lucas Cive Barbosa does not currently hold any positions in committees, which is why item 7.4 is not being presented.
Date of Birth |
Profession |
Is part of a Committee? |
Name of the Committee |
Position on the Committee |
Date of election on the Committee |
Date of Investiture on the Committee |
Time Period of the Committee's Term |
Date of 1st Term (Committee) |
06/17/1984 |
Business Administrator |
Não |
N/A |
N/A |
N/A |
N/A |
N/A |
N/A |
Professional Experience: |
Mr. Lucas Cive Barbosa is a candidate for a full member position on the Company’s Board of Directors, nominated by shareholders Novonor and NSP Investimentos. Mr. Lucas Cive Barbosa holds a bachelor’s degree in Business Administration from the School of Economics and Business Administration of the University of São Paulo and an MBA from the MIT – Sloan School of Management. He has served as Chief Financial and Information Technology Officer at Novonor S.A. since July 2024, and previously held the same position at OEC S.A. from 2022 to 2025. He has over 20 years of experience in the financial sector, having served as Executive Director at Alvarez & Marsal (2020–2022), Director at BBC Digital – JSL (2019–2020), Chief Financial Officer at Simpar S.A. – JSL (2018–2019), and Corporate Finance Director at Odebrecht Engenharia e Construção S.A. (2015–2018). He has also led financial teams in highly complex projects, such as debt restructuring, M&A, strategic planning, investor relations, among others. Mr. Lucas declares that he is not considered a Politically Exposed Person under applicable regulations and that he does not hold positions or functions in third sector organizations. |
Convictions: |
The Candidate hereby declares that he does not have: (a) any criminal conviction; (b) any conviction in administrative proceedings by the CVM, the Central Bank of Brazil, or the Superintendence of Private Insurance; and (c) any final conviction, in the judicial or administrative sphere, that has suspended or disqualified him from practicing any professional or commercial activity. |
7.5. Inform the existence of marital relationship, stable union
or kinship up to the second degree between: a. administrators of the issuer; b. (i) administrators of the issuer and (ii) administrators
of subsidiaries, whether directly or indirectly controlled by the issuer; c. (i) administrators of the issuer or of its subsidiaries,
whether directly or indirectly controlled, and (ii) direct or indirect controllers of the issuer; d. (i) administrators of the issuer
and (ii) administrators of the direct and indirect controlling companies of the issuer.
Not applicable, as there is no marital relationship, stable union or kinship
up to the second degree between the candidates and the individuals mentioned in items ‘a’, b’, c’, and ‘d’
above.
7.6. Inform about the existence of subordination, service provision
or control relationships maintained during the last 3 (three) fiscal years between administrators of the issuer and: a. company controlled,
directly or indirectly, by the issuer, except for those in which the issuer holds, directly or indirectly, an interest equal to or greater
than 99% (ninety-nine percent) of the share capital; b. direct or indirect controller of the issuer; c. if relevant, supplier, client,
debtor or creditor of the issuer, of its controlled companies or of the controlling companies or controlled companies of any of these
person.
2024:
Manager’s Name |
|
Type of Person |
|
Manager’s CPF |
|
Nationality |
|
No. of Passport |
Lucas Cive Barbosa |
|
Brazilian |
|
323.198.758-08 |
|
Brazil |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Position in the Company |
|
|
|
|
|
|
|
|
|
|
|
|
Effective Member of the Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related Person |
|
Type of Person |
|
CPF/CNPJ of the Related Person |
|
Nacionality |
|
No. of Passport |
Novonor S.A. – Em Recuperação Judicial |
|
Legal Entity |
|
05.144.757/0001-72 |
|
Brazil |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Position in the Related Person |
|
Type of Relationship with the Related Person |
|
Type of related person |
|
|
|
|
|
|
Chief Financial and Information Technology Officer |
|
Subordination |
|
Indirect Controller |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2023:
Manager’s Name |
|
Type of Person |
|
Manager’s CPF |
|
Nationality |
|
No. of Passport |
Lucas Cive Barbosa |
|
Brazilian |
|
323.198.758-08 |
|
Brazil |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Position in the Company |
|
|
|
|
|
|
|
|
|
|
|
|
Effective Member of the Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related Person |
|
Type of Person |
|
CPF/CNPJ of the Related Person |
|
Nacionality |
|
No. of Passport |
OEC S.A. - Em Recuperação Judicial |
|
Legal Entity |
|
33.950.222/0001-24 |
|
Brazil |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Position in the Related Person |
|
Type of Relationship with the Related Person |
|
Type of related person |
|
|
|
|
|
|
Chief Financial and Information Technology Officer |
|
Subordination |
|
Company under common control |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2022:
Manager’s Name |
|
Type of Person |
|
Manager’s CPF |
|
Nationality |
|
No. of Passport |
Lucas Cive Barbosa |
|
Brazilian |
|
323.198.758-08 |
|
Brazil |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Position in the Company |
|
|
|
|
|
|
|
|
|
|
|
|
Effective Member of the Board of Directors |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Related Person |
|
Type of Person |
|
CPF/CNPJ of the Related Person |
|
Nacionality |
|
No. of Passport |
OEC S.A. - Em Recuperação Judicial |
|
Jurídica |
|
33.950.222/0001-24 |
|
Brazil |
|
N/A |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Position in the Related Person |
|
Type of Relationship with the Related Person |
|
Type of related person |
|
|
|
|
|
|
Chief Financial and Information Technology Officer |
|
Subordination |
|
Company under common control |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
BRASKEM S.A.
National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70
State Registration (NIRE) 29300006939
A Publicly Held Company
MANAGEMENT PROPOSAL
FOR THE EXTRAORDINARY GENERAL MEETING OF BRASKEM S.A.
TO BE HELD ON NOVEMBER 13, 2025
ANNEX II
Report detailing the origin and justification
of the proposed amendments to the Company's Bylaws and analyzing their legal and economic effects, presented in table format, pursuant
to Article 12, item II of CVM Resolution 81.
Current Wording |
Proposed Wording |
Rationale of the Proposed Amendment |
Article 2
The objectives of the Company are as follows:
|
Article 2
The objectives of the Company are as follows:
|
Unchanged wording. |
a) the manufacture, trading, import and export of chemical and petrochemical products and petrochemical derivatives; |
a) the manufacture, commercialization, trading, distribution, import and export of chemical products, and petrochemical products, thermoplastic resins, their respective compounds, processed and petrochemical derivatives products, including those from biotechnology and renewable sources, as well as recycled products; |
To improve and detail the wording of the corporate purpose, aligning it with the Company’s current strategy and the activities already carried out, considering its innovation portfolio and the expansion of its portfolio of renewable-source products, recycled products, and other chemicals and petrochemicals. |
b) production, distribution and trading of units such as: steam, water, compressed air, industrial gases, as well as the provision of industrial services; |
b) production, distribution and trading of units such as: steam, water, compressed air, industrial gases, as well as the provision of industrial services; |
Unchanged wording. |
c) production, distribution and trading of electricity for its own consumption and that of other companies; |
c) production, distribution and trading of electricity for its own consumption and that of other for third-party companies; |
Wording improvement. |
d) the taking of holdings in other companies, pursuant to Law No. 6404/76, as a holder of quotas or shares; |
d) the taking of holdings in other companies, pursuant to Law No. 6404/76, as a holder of quotas or shares; |
Wording improvement, without limitation to Law No. 6,404/76. |
e) the manufacture, distribution, trading, import and export of gasoline, diesel oil, liquefied petroleum gas (LPG), and other oil derivatives; |
e) the manufacture, distribution, trading, import and export of gasoline, diesel oil, liquefied petroleum gas (LPG), and other oil derivatives, natural gas derivatives, or raw materials from renewable or circular sources; |
Wording adjustment intended to provide greater detail regarding the sources of raw materials that may be used by the Company in its operations. |
f) the transportation, representation and consignment of petrochemical products and by-products, compounds and derivatives, such as polypropylene, polypropylene films, polyethylene, elastomers and their respective manufactured products; |
f) the transportation, including maritime
and river navigation, representation and consignment of chemical and petrochemical products
and by-products, thermoplastic resins, their respective
compounds, processed and derivatives, such as polypropylene, polypropylene films, polyethylene,
elastomers, including biotechnology and their respective manufactured
products from renewable sources, as well as recycled products;
|
Wording adjustment to expressly include the transportation activity also through maritime and river navigation, in accordance with sector regulations. Additionally, the adjustments aimed to improve the wording of the corporate purpose, aligning it with the Company’s current reality, which focuses on innovation and the expansion of its portfolio of renewable-source products, recycled products, and others. |
g) the free lease or loan of assets that are owned or possessed thereby because of a commercial leasing agreement, provided that this is carried out as an ancillary activity to the main corporate purpose of the Company; and |
g) the free lease or loan of assets that are owned or possessed thereby because of a commercial leasing agreement, provided that this is carried out as an ancillary activity to the main corporate purpose of the Company; and |
Unchanged wording. |
h) the provision of services related to the activities above. |
h) the provision of services related to the activities above and similar ones; and
|
Aprimoramento de redação. |
Sem correspondência anterior. |
i) research, development, licensing, and direct or indirect exploitation of (i) proprietary or third-party technologies in the fields of chemistry, petrochemistry, plastics, biotechnology, biorefinery, energy and/or related to the activities above or in businesses adjacent to the corporate purpose; (ii) business models and/or digital technologies related to the activities above or in businesses adjacent to the corporate purpose. |
Inclusion of an item for the purpose of detailing the wording of the corporate purpose to expressly address investments in the development and potential exploitation of technologies related to processes and products that are already part of Braskem’s activities, both petrochemical and renewable in nature, as well as in biotechnology, circular economy, digital technologies, and innovation promotion projects. |
Sem correspondência anterior |
Article 20
The election of the members of the Board of Directors
shall be carried out through a slate system, and individual voting for candidates shall be prohibited, except for the right to separate
election provided for in article 141, paragraphs 4 and 5 of Law No. 6,404/76, when applicable.
Paragraph 1 – For clarification purposes,
the provision in the caput shall not apply to the individual replacement of up to the majority of the seats on the Board of Directors
due to vacancies. |
Inclusion of a new article intended to improve the rules and structure of the election process for the Board of Directors at the General Shareholders’ Meeting, providing greater transparency to the election process |
|
Paragraph 2 – In the election referred
to in this Article, only the following may run: (a) the slate nominated by the Board of Directors, observing, when applicable, the provisions
of the Shareholders’ Agreements filed at the Company’s headquarters; and (b) the slate or slates nominated, as provided for
in paragraph 4 of this Article, by any shareholder or group of shareholders.
Paragraph 3 – The Board of Directors
shall, by the date of the call notice for the General Meeting convened to elect all members of the Board of Directors, disclose in the
management proposal or other materials made available for the Meeting the names of the candidates included in the slate proposed by the
Board of Directors and provide the information and documents required by applicable law and regulations.
Paragraph 4 – The shareholder or group
of shareholders wishing to propose an alternative slate to run for the Board of Directors must, at least 25 (twenty-five) days prior to
the date scheduled for the General Meeting, submit in writing to the Board of Directors, with a copy to the Company’s Investor Relations
Officer, the nomination of the candidates on their proposed slate, accompanied by the information and documents required by applicable
law and regulations, and its disclosure must comply with the applicable rules.
|
|
|
Paragraph 5 – If one or more candidates
on the proposed slate are replaced, the Board of Directors or the shareholder or group of shareholders, as applicable, must immediately
inform the Company’s Investor Relations Officer, providing the information and documents required by applicable law and regulations
regarding the substitute candidates.
Paragraph 6 – Among the names nominated
by the Board of Directors or by shareholders, those who qualify as Independent Directors must be identified, in accordance with the provisions
of Article 18 above.
Paragraph 7 – It is prohibited for the
same shareholder, individually or jointly with other shareholders, to submit more than one slate. However, the same person may be included
in two or more slates, including the one nominated by the Board of Directors.
Paragraph 8 – Each shareholder may vote
in favor of only one slate, and the candidates on the slate receiving the highest number of votes at the General Meeting shall be declared
elected.
Paragraph 9 – In the event of election
of the members of the Board of Directors through the cumulative voting process, the slate election shall no longer apply, and the candidates
for the Board of Directors shall be those included in the slates referred to in this Article, as well as any other candidates nominated,
provided that the information and documents required by applicable law and regulations regarding the candidates are submitted to the General
Meeting. |
|
Article 26
The Board of Directors is responsible for: |
Article 267
The Board of Directors is responsible for: |
Renumbering due to the inclusion of provisions. |
(ii) deciding on operational or expansion investments for the Company and its controlled companies in amounts greater than one hundred million Reais (R$ 100,000,000.00); |
(ii) deciding on operational or expansion investments for the Company and its controlled companies in amounts greater than one hundred million two hundred and forty million Reais (R$240,000,000.00 100,000,000.00); |
Monetary update of the approval threshold, by the Board of Directors, for operational or expansion investments of the Company and its controlled entities, in accordance with the inflation index (IPCA) for the period, calculated since the date this threshold was established, in 2010. |
(x) appointing and replacing the independent auditors of the Company and its controlled companies; |
(x) appointing and replacing
the independent auditors of the Company and its controlled companies;
|
Wording adjustment to exclude from the responsibilities of the Board of Directors the selection and replacement of independent auditors of the Company’s controlled entities, allowing the Executive Board to have autonomy over this matter and enabling the Board of Directors to focus on strategic issues. |
(xiv) approving the acquisition of assets (except those classified under the item xv below) and the contracting of services of any kind by the Company and any of its controlled companies in the annual amounts exceeding two hundred million Reais (R$200,000,000.00), in accordance with the Company’s Business Plan; |
(xiv) approving the acquisition of assets (except those classified under the item xv below) and the contracting of services of any kind by the Company and any of its controlled companies in the annual amounts exceeding two hundred million four hundred and eighty million Reais (R$480,000,000.00200,000,000.00), in accordance with the Company’s Business Plan; |
onetary update of the approval threshold, by the Board of Directors,
for the matters indicated alongside, in accordance with the inflation index (IPCA) for the period, calculated since the date this threshold
was established, in 2010.
|
(xviii) decide on the execution of contracts between the Company or any subsidiary of the Company on the one hand, and on the other hand, any of its related parties, as defined in the Company's policy that regulates this matter, in amounts greater than R$ 20,000 .000.00 (twenty million reais) per operation or higher, together, to R$ 60,000,000.00 (sixty million reais) per fiscal year; |
(xviii) decide on the execution of contracts between the Company or any subsidiary of the Company on the one hand, and on the other hand, any of its related parties, as defined in the Company's policy that regulates this matter, in amounts greater than R$ 20,000 .000.00 30,000,000.00(twenty thirty million reais) per operation or higher, together, to R$ 60,000,000.00 90,000,000.00(sixty ninety million reais) per fiscal year, considering that this refers to the set of related transactions, pursuant to the definition of related transactions provided in CVM Resolution No. 80/22. |
Adjustments to reflect the monetary update of the approval threshold
by the Board of Directors, in accordance with the inflation index (IPCA) for the period, calculated since the date of the last update
of this threshold, in 2018.
Additionally, this item was revised to clarify that, for the purposes
of the Board of Directors’ approval threshold regarding transactions with Related Parties, on a consolidated basis per fiscal year,
the set of related transactions must be considered, pursuant to the definition of related transactions provided in CVM Resolution No.
80/22. |
Sem correspondência anterior |
(xxxi) to decide annually on the maintenance or adjustment by the IPCA index or another officially recognized inflation index that may replace it, of the amounts and limits set forth in items II, XIV, XVII, XVIII, and XX of article 26 of these Bylaws. |
Inclusion of a specific responsibility to allow the Board of Directors to annually assess the relevance of updating the approval thresholds under its authority, based on inflation variation measured by officially recognized inflation índices. |
BRASKEM S.A.
National Register of Legal Entities (CNPJ) No. 42.150.391/0001-70
State Registration (NIRE) 29300006939
A Publicly Held Company
MANAGEMENT PROPOSAL
FOR THE EXTRAORDINARY GENERAL MEETING OF BRASKEM S.A.
TO BE HELD ON NOVEMBER 13, 2025
ANNEX III
Copy of the Company's Bylaws with the proposed amendments clearly
highlighted, pursuant to article 12, item I of CVM Resolution 81.
Consolidated Bylaws of the Company
CHAPTER I
NAME, HEADQUARTERS, PURPOSE AND DURATION
Article 1
BRASKEM S.A., a publicly listed company, with headquarters
and under the jurisdiction of the Municipality of Camaçari, State of Bahia, is governed by these bylaws and by the appropriate
legislation.
First Paragraph – Due to listing of the company within
the Level 1 segment of the São Paulo Stock Exchange B3 S.A. – Brasil, Bolsa, Balcão(“B3”), the Company,
its shareholders, Administrators and Fiscal Board members are subject to the provisions in the B3 Level 1 Listing Regulation (“Regulation”).
Second Paragraph – The Company may, through a document
signed by its Executive Board, constitute, transfer or close branches, agencies and offices in any part of Brazil or outside it.
Article 2
The objectives of the Company are as follows:
| a) | the manufacture, commercialization, trading, distribution,
import and export of chemical products, and petrochemical products,
thermoplastic resins, their respective compounds, processed and petrochemical
derivatives products, including those from biotechnology and renewable sources, as well as recycled
products; |
| b) | production, distribution and trading of units such as: steam, water, compressed air, industrial gases,
as well as the provision of industrial services; |
| c) | production, distribution and trading of electricity for its own consumption and that
of other for third-party companies; |
| d) | the taking of holdings in other companies, pursuant to Law No. 6404/76,
as a holder of quotas or shares; |
| e) | the manufacture, distribution, trading, import and export of gasoline, diesel oil, liquefied petroleum
gas (LPG), and other oil derivatives, natural gas derivatives, or raw materials from renewable or circular
sources; |
| f) | the transportation, including maritime and river navigation, representation
and consignment of chemical and petrochemical products and by-products,
thermoplastic resins, their respective compounds, processed
and derivatives, such as polypropylene, polypropylene films, polyethylene, elastomers, including biotechnology
and their respective manufactured products from renewable sources, as well as recycled products; |
| g) | the free lease or loan of assets that are owned or possessed thereby because of a commercial leasing agreement,
provided that this is carried out as an ancillary activity to the main corporate purpose of the Company; and |
| h) | the provision of services related to the activities above and similar ones;
and |
| i) | research, development, licensing, and direct or indirect exploitation of (i) proprietary or third-party
technologies in the fields of chemistry, petrochemistry, plastics, biotechnology, biorefinery, energy and/or related to the activities
above or in businesses adjacent to the corporate purpose; (ii) business models and/or digital technologies related to the activities above
or in businesses adjacent to the corporate purpose. |
Article 3
The Company’s term of duration is unspecified.
CHAPTER II
CAPITAL STOCK AND SHARES
Article 4
The share capital is eight billion, forty-three million, two hundred
and twenty-two thousand, eighty reais and fifty cents (R$ 8,043,222,080.50), divided into seven hundred and ninety-seven million, two
hundred and seven thousand, eight hundred and thirty-four (797,207,834) shares, of which 451,668,652 (four hundred and fifty-one million,
six hundred and sixty-eight thousand, six hundred and fifty-two) common shares, three hundred and forty-five million, sixty thousand,
three hundred and ninety-two (345,060,392) class “A” preferred shares; and four hundred and seventy-eight, seven hundred and
ninety (478,790) class “B” preferred shares.
First Paragraph - Irrespectively of the statutory path taken,
the Company is authorized, by resolution of the Board of Directors, to increase its Capital Stock until said stock reaches a total of
one billion, one hundred and fifty two million, nine hundred and thirty seven thousand, nine hundred and seventy (1,152,937,970) shares,
of which five hundred and thirty five million, six hundred and sixty one thousand, seven hundred and thirty one (535,661,731) are to be
common shares, six hundred and sixteen million, six hundred and eighty two thousand, four hundred and twenty one (616,682,421) are to
be Class “A” preferred shares and five hundred and ninety three thousand, eight hundred and eighteen (593.818) are to be Class
“B” preferred shares, it being certain that the number of preferred shares not entitled to vote, or with a restricted right
to vote shall not exceed the limit of 2/3 of the entire capital of the Company (“Authorized Capital”).
Second Paragraph - The proportion verified above between
the numbers of shares of the various classes of the Company’s preferred shares may be modified, dispensing the formality set forth
in Article 136, paragraph 1, of Law No. 6404/76.
Article 5
The class “B” preferred shares will always be paid
in full, using resources assigned under the terms of the law on fiscal incentives for projects in the Northeast of Brazil.
Sole Paragraph - Shares paid in with resources from the
Northeast Investment Fund - FINOR, created by Decree-Law No 1,376, of December 12, 1974, must remain as non-transferable registered shares
for a period of four (4) years from the date that they are converted by that Fund for investors in accordance with Article 19 of Decree-Law
No 1,376/74, except in the event that these shares are converted for the private individuals to which Article 3 of the same Decree-Law
refers.
Article 6
All of the Company’s shares are held in book entry transfer
form, in the name of their holders, and will be held in a deposit account in a financial institution without the issue of certificates.
First Paragraph - The cost for the service of transferring
ownership of the shares that may be charged by the financial institution acting as depository, may be passed on to shareholders in accordance
with the terms of the third paragraph of Article 35, of Law No 6,404/76.
Second Paragraph - The General Shareholders’ Meeting
may authorize the conversion of class "A" preferred shares into common shares by means of the affirmative vote of shareholders
representing the majority of the voting capital of the Company, which shall, however, establish: (a) the number of shares to be converted;
(b) the exchange ratio applicable to such conversion; and (c) the date on which the conversion of shares will occur.
Third Paragraph - With regard to the class “B”
preferred shares, once the period of non-transferability established in special legislation has elapsed, the said shares may be converted
into class “A” preferred shares at any time, through a written request to the Company, in the proportion of two (2) class
“B” preferred shares received for each class “A” preferred share converted.
Fourth Paragraph - All of the Company’s shares will
be entitled to tag along rights in the event that the control of the Company is transferred, with all shares qualifying for the same price
per share paid to the disposing shareholders, pursuant to the terms of Chapter III of these bylaws.
Article 7
Subscription and payment in full for the shares will be subject
to the following criteria:
a) the issue, quantity, price, types or classes of shares to be
issued by the Company shall, depending on the case, be established by either the General Meeting or the Board of Directors, always observing
the Authorized Capital in the latter hypothesis;
b) the minimum amount in shares subscribed will be in accordance
with the prevailing legislation;
c) the period for making full payment for the subscribed shares
will be established by the Board of Directors or the General Meeting, depending on the case, for each capital increase;
d) payment for the shares in assets that are not credits in current
legal tender will depend on approval by the General Meeting;
e) there will be no preemptive rights for the subscription of shares
issued under the terms of the special Law on fiscal incentives (Article 172, First
Paragraph of Law No 6,404/76); nor will holders of shares subscribed
with funds originating from fiscal incentives have preemptive rights to subscribe any new shares;
f) without affecting the terms of the sole paragraph below,
in exercising preemptive rights to subscribe to new shares and/or other securities issued by the Company, shareholders are guaranteed
a period of thirty (30) days to carry out the subscription, starting from the date of publication of the respective notice to shareholders;
g) the Company may issue subscription warrants at the decision
of the Board of Directors, up to the limit of the Authorized Capital.
Sole Paragraph - Except where there is an issue of
common shares, or other securities convertible into common shares, the Board of Directors or the General Meeting may, depending on circumstances,
exclude preemptive rights for former shareholders, or reduce the respective term in any issue of shares, debentures, subscription warrants
or other securities, the placement of which is made through a stock exchange, a public subscription or in exchange for shares in a public
offer to acquire control, in accordance with the terms of the law.
Article 8
Each common share carries the right to one vote on the decisions
of the General Meeting.
Article 9
Preferred shares will not have voting rights, but will nevertheless
enjoy the following privileges:
a) Class “A” and “B” preferred shares will
have equal priority in the distribution in each financial year, of a minimum, non-cumulative dividend, of six per cent (6%) of its unit
value, as defined in item “g” below, in accordance with the income available for distribution to shareholders. This dividend
must be paid, except in the case of a decision by the General Meeting, or the Board of Directors, there is a distribution of interim dividends
(Article 46, 4th Paragraph), within sixty (60) days of the date on which it is declared, and in any case, before the end of the same financial
year;
b) common shares will only be entitled to dividends after the payment
of dividends on the preferred shares referred to in item “a” of this article;
c) following the implementation of the terms of item “a”
of this article and a dividend being guaranteed on the common shares of six per cent (6%) of their unit value, as defined in item “g”
below, the class “A” preferred shares
will have equal claim with the common shares to the distribution
of the remaining income. The class “B” preferred shares will not participate in the distribution of the remaining income after
the said shares have received the minimum dividend referred to in item “a” of this article;
d) only the common and class “A” preferred shares
will be entitled to participate in the distribution, by the Company, of shares resulting from the incorporation of reserves into the capital
stock;
e) the class “A” and “B” preferred shares
are guaranteed priority in the reimbursement of the Capital Stock;
f) full payment for the subscription of shares by FINOR will be
affected through the deposit of the corresponding amount in an escrow account with the Banco do Nordeste do Brasil S.A. in the name of
the Company, with the relevant release of funds occurring immediately after the BRASKEM S.A. National Register of Legal Entities (C.N.P.J.)
No. 42.150.391/0001-70 NIRE 29300006939 A Publicly-Held Company publication, in the Official Gazette of the Commercial Registry Certificate
of the filing of the Minutes of the Meeting of the Board of Directors that decides on the subscription;
g) the unit value of the shares will be obtained by dividing the
capital stock by the number of shares in the market.
Sole Paragraph - The preferred shares without voting
rights that have fixed or minimum dividends, when issued, will acquire such rights in the event that the Company does not pay the fixed
or minimum dividends to which the shares are entitled for three consecutive financial years, and will retain these rights until such time
as these dividends are paid, in the event that they are not cumulative, or until the overdue cumulative dividends are paid, in all cases
pursuant to Paragraph 1 of Article 111 of Law No. 6,404/76.
CHAPTER III
JOINT SALE RIGHTS.
Article 10
In the event that the controllers of the Company dispose control
of the Company at any time, the same disposing party(ies) will be obliged to include in the document governing the same cession of control,
an obligation on the part of the acquiring party(ies) to make, within a period of thirty (30) days of the formal transfer of the shares
representing the controlling stake and affected through the financial institution responsible for the custody of the Company’s shares,
a public offer for the purchase of
all shares issued by the Company, independent of the type or class
of share, for the same price per share paid to the disposing shareholder(s).
Article 11
Pursuant to Article 10 above, transfer of control is understood
to mean the sale, disposal and/or transfer of the shares representing the control of the Company, which removes from the disposing party(ies)
the condition of the controller of the Company, whether in isolation or jointly with third parties, and transfers this to any company
that is not (a) the controlling company, directly or indirectly, of the disposing shareholder(s); (b) controlled directly or through a
stake held in a controlling block by the controlling shareholders of the ceding party(ies); or (c) controlled, whether directly or indirectly
by the disposing shareholder(s).
Sole Paragraph - Notwithstanding the terms of Article 11
above, the sale, disposal and/or transfer of shares of the Company will not be considered to constitute a transfer of control, when these
operations occur between shareholders that are members of the controlling block and/or signatories to agreements between shareholders
of the Company regulating the exercise of political rights over the shares pertaining to members of the controlling block.
Article 12
The right of joint sale established here in Chapter III will not
apply in the event that the transfer of control of the Company occurs: (a) as the result of a court Resolution or act, such as judicial
seizure or sentence or (b) as the result of a final decision by regulatory authorities, including the Brazilian Anti-Trust Commission
(CADE), that obliges the controlling shareholder(s) of the Company to divest part or all of the shares in the Company that they hold.
CHAPTER IV
PERMANENT BODIES OF THE COMPANY
Article 13
The following are permanent bodies of the Company:
a) the General Meeting;
b) the Board of Directors;
c) the Executive Board;
d) the Fiscal Board.
CHAPTER V
THE GENERAL MEETING
Article 14
The General Meeting will be held ordinarily during the first four
months following the end of each financial year; and extraordinarily whenever the interests of the Company so require.
Sole Paragraph - The General Meeting will be called by the
Board of Directors or in the form established by law.
Article 15
Notice of the General Meeting will be given in the written media,
pursuant to the terms established by law.
Article 16
Participation in the General Meeting is restricted to shareholders
whose shares are held in the custody at the financial institution indicated by the Company up to eight (8) days prior to the holding of
the said Meeting.
First Paragraph - Shareholders may appoint proxies pursuant
to the terms of the law and rules published by the Brazilian Securities and Exchange Commission.
Second Paragraph – For the purposes of exercising
the right set forth in paragraph 4 of Article 141 of Law No. 6,404/76, shareholders must prove to the Meeting the continuous title to
the minimum ownership interest required by such provision for a period of three (3) months immediately prior to the holding of the General
Meeting and will be eligible to exercise the mentioned right only in relation to the shares satisfying such requirement.
Third Paragraph – After signing the Register of Attendance,
the shareholders will elect the Chairman and the Secretary to preside over the deliberations of the General Meeting.
Article 17
The General Meeting shall be responsible for, among other duties
assigned thereto by law, deliberating on the following subjects:
| (i) | altering the preferences, advantages and/or conditions for the redemption or amortization of one or more
classes of preferred shares in which the Capital of Stock of the Company is divided; |
| (ii) | creation of classes of preferred shares more favorable than the existing classes; |
| (iii) | conversion of preferred shares into common shares of the Company; |
| (iv) | participation in a group of companies, according to the definition contained in Article 265 of Law No.
6404/76; |
| (v) | amendment to the Company’s bylaws; |
| (vi) | increase or reduction of the Company’s Capital of Stock beyond the limit of the authorized capital,
as well as redemption or amortization of its shares; |
| (vii) | transformation, consolidation, spin-off, merger or merger of shares involving the Company; |
| (viii) | increase or reduction in the number of members in the Company’s Board of Directors; |
| (ix) | Resolution of bankruptcy, judicial and extrajudicial reorganization of the Company, or, furthermore, winding-up,
liquidation or lifting of the liquidation; |
| (x) | alteration of the dividends policy or the minimum mandatory dividends set forth in the Company’s
bylaws; |
| (xi) | issue by the Company of debentures convertible into common shares or subscription warrants, observing
the provision in Article 26, xxiv, below; |
| (xii) | decision on the delisting of shares or, if delisted, the obtaining of any new registration of the Company
as a publicly-held Company; |
| (xiii) | appraisal of the assets which the shareholder contributes to the Capital of Stock increase; |
| (xiv) | election and substitution of members of the Board of Directors and Fiscal Council; and |
| (xv) | fix determination of the annual compensation of administrators. |
CHAPTER VI
THE BOARD OF DIRECTORS
Article 18
The Board of Directors of the Company is composed of eleven (11)
members and their respective alternates, whether resident of Brazil or not, who are elected and may be removed from office at any time
by the General Meeting.
First Paragraph – At least twenty percent (20%) of
the members of the Board of Directors shall be independent directors, in accordance with the definition contained in the Company's policies.
Second Paragraph – When, by virtue of compliance with
the percentage referred to in Paragraph 1 above, the result is a fractional number of directors, there shall be made a rounding up to
the subsequent whole number.
Third Paragraph – The directors elected by separate
vote shall be considered independent.
Article 19
The General Meeting must appoint from among the members of the
Board of Directors, the Chairman and Vice-Chairman, and has the power to remove them from office at any time, observing the provisions
in the Shareholders’ Agreement filed at the Company’s headquarters.
Sole Paragraph – The position of Chief Executive Officer
and Chairman of the Board of Directors cannot be held at the same time by the same individual except in the cases and under the terms
set out in the Regulation.
Article 20
The election of the members of the Board of Directors
shall be carried out through a slate system, and individual voting for candidates shall be prohibited, except for the right to separate
election provided for in Article 141, paragraphs 4 and 5 of Law No. 6,404/76, when applicable.
First Paragraph – For clarification
purposes, the provision in the caput shall not apply to the individual replacement of up to the majority of the seats on the Board of
Directors due to vacancies.
Second Paragraph – In the election
referred to in this Article, only the following may run: (a) the slate nominated by the Board of Directors, observing, when applicable,
the provisions of the Shareholders’ Agreements filed at the Company’s headquarters; and (b) the slate or slates nominated,
as provided for in paragraph 4 of this Article, by any shareholder or group of shareholders.
Third Paragraph – The Board
of Directors shall, by the date of the call notice for the General Meeting convened to elect all members of the Board of Directors, disclose
in the management proposal or other materials made available for the Meeting the names of the candidates included in the slate proposed
by the Board of Directors and provide the information and documents required by applicable law and regulations.
Fourth Paragraph – The shareholder
or group of shareholders wishing to propose an alternative slate to run for the Board of Directors must, at least 25 (twenty-five) days
prior to the date scheduled for the General Meeting, submit in writing to the Board of Directors, with a copy to the Company’s Investor
Relations Officer, the nomination of the candidates on their proposed slate, accompanied by the information and documents required by
applicable law and regulations, and its disclosure must comply with the applicable rules.
Fifth Paragraph – If one or
more candidates on the proposed slate are replaced, the Board of Directors or the shareholder or group of shareholders, as applicable,
must immediately inform the Company’s Investor Relations Officer, providing the information and documents required by applicable
law and regulations regarding the substitute candidates.
Sixth Paragraph – Among
the names nominated by the Board of Directors or by shareholders, those who qualify as Independent Directors must be identified, in accordance
with the provisions of Article 18 above.
Seventh Paragraph – It
is prohibited for the same shareholder, individually or jointly with other shareholders, to submit more than one slate. However, the same
person may be included in two or more slates, including the one nominated by the Board of Directors.
Eighth Paragraph – Each shareholder
may vote in favor of only one slate, and the candidates on the slate receiving the highest number of votes at the General Meeting shall
be declared elected.
Ninth Paragraph –
In the event of election of the members of the Board of Directors through the cumulative voting process, the slate election shall no longer
apply, and the candidates for the Board of Directors shall be those included in the slates referred to in this Article, as well as any
other candidates nominated, provided that the information and documents required by applicable law and regulations regarding the candidates
are submitted to the General Meeting..
Article 201
The members of the Board of Directors will have a unified term
of office of two (2) years, with reelection being permitted.
Sole Paragraph - The members of the Board of Directors will
take office by signing the instruments of investiture drawn up in the Book of Minutes of the Board of Directors’ Meetings, as well
as other documents required by the applicable legislation and the Instrument of Consent of the Administrators set forth in the Regulation
and the polices in effect at the
Company, and will remain in their positions until their successors
take office.
Article 212
The terms of office of the Chairman and Vice-Chairman will be two
(2) years, with re-election being permitted.
Article 223
In the absence or temporary impairment, the members of the Board
of Directors will be replaced by their respective alternates. In the absences or temporary impairment of the Chairman, the Vice-Chairman
will preside over the Board of Directors. In the absence and/or temporary and simultaneous impairment of the Chairman and the Vice-Chairman,
the Chairman will nominate one of the other members of the Board to replace him/her as President of the Board of Directors.
Article 234
In the event of a vacancy in the position of Member, the substitute
shall automatically become its alternate in case no other Member in nominated by the remaining Members from among the alternate Members,
observing the provision in the Shareholders’ Agreement filed at the Company’s headquarters, and shall serve until the first
General Meeting in which its name may be ratified or substituted by the shareholders. The substitute elected to fill the position must
complete the remaining management term of the replaced member.
Article 245
The Board of Directors will normally meet every three (3) months,
and extraordinarily, whenever summoned by the Chairman, Vice-Chairman or by any two (2) of its members.
First Paragraph - Between the day of calling and the day
of holding the meeting of the Board of Directors, an interval of at least 10 (ten) days will exist, unless the majority of its acting
members determine a shorter interval, which will not, however, be less than forty eight (48) hours, in addition to making duly supported
docket available.
Second Paragraph - The Board of Directors will only deliberate
in the presence of the majority of its acting members, Board members however having the option of being represented by any other Board
member or alternate that they may nominate, and decisions will be taken by a majority vote, observing the provisions in the Shareholders’
Agreement filed at the Company’s headquarters.
Article 256
The aggregate annual compensation of the Company’s administrators
will be set by the General Meeting, and the Board of Directors will be liable for establishing their individual compensation.
Article 267
The Board of Directors is responsible for:
| (i) | setting the general business policy of the Company; |
| (ii) | deciding on operational or expansion investments for the Company and its controlled companies in amounts
greater than one hundred million two hundred and forty million Reais (R$240,000,000.00
100,000,000.00; |
| (iii) | deciding the Company’s Business Plan, which must include its short-, medium- and long-term business
and strategic objectives as well as yearly and multi-year budgets, and monitoring implementation thereof; |
| (iv) | approving proposals for policies to be applied generally within the Company, including the contracting
of insurance; |
| (v) | providing an opinion on the management report and financial statements at the end of each financial year,
as well as on the proposal for the distribution of net profits ascertained, as well as allocation of reserves; |
| (vi) | approving the Operating Rules for the Board of Directors, which will rule on such subjects as the appointment
of a Secretary and specialized committees to aid the Board in its decision-making process, as well as approving any Internal Rules of
such committees; |
| (vii) | approving the criteria for the employee participation in the profit sharing program; |
| (viii) | appointing and dismissing the Directors of the Company and establishing their attributions and compensation,
pursuant to the aggregate budget established by the General Meeting, the provisions of these bylaws and the Shareholders’ Agreements
filed at the Company’s headquarters; |
| (ix) | monitoring management, examining at any time, the books and papers of the Company, requesting information
on contracts signed or due to be signed, and on any other acts; |
| (x) | appointing and replacing the independent auditors of the Company and
its controlled companies; |
| (xi) | calling the Annual and Extraordinary General Meeting(s); |
| (xii) | submitting to the General Meeting proposals regarding consolidation, spinoff, merger, merger of shares
involving the Company or the winding-up thereof, as well as modifications to the bylaws, including increases in the Authorized Capital; |
| (xiii) | deciding on the participation of the Company in companies, partnerships, profit and non-profit associations
or consortiums; |
| (xiv) | approving the acquisition of assets (except those classified under the item xv below) and the contracting
of services of any kind by the Company and any of its controlled companies in the annual amounts exceeding two
hundred million four hundred and eighty million Reais (R$480,000,000.00200,000,000.00),
in accordance with the Company’s Business Plan; |
| (xv) | approving the acquisition of assets for the non-current assets (recorded under the item “investments”)
of the Company or its controlled companies, in transactions that contemplate, per transaction or jointly per fiscal year, amounts exceeding
thirty percent (30%) of the non-current assets of the Company, pursuant to the latest annual balance sheet disclosed; |
| (xvi) | approving the execution of free-lease, disposal, assignment or transfer of assets pertaining to the non-current
assets of the Company or its controlled companies in transactions which contemplate, per transaction or jointly per fiscal year, amounts
exceeding ten percent (10%) of the noncurrent assets of the Company, pursuant to the latest annual balance sheet disclosed; |
| (xvii) | deciding on the encumbrance, disposal or fiduciary assignment of the assets pertaining to the non-current
assets of the Company or its controlled companies in operations contemplating, per transaction or jointly per fiscal year, amounts exceeding
twenty percent (20%) of the noncurrent assets of the Company, pursuant to the latest annual balance sheet disclosed, or exceeding three
hundred and fifty million Reais (R$ 350,000,000.00), provided such limits do not apply to the encumbrance, assignment or fiduciary alienation
by the Company or its controlled companies of any asset belonging to the non-current assets, which is performed to guarantee (a) financing
of the acquisition of such asset and (b) legal proceedings filed by or against the Company or its controlled companies; |
| (xviii) | decide on the execution of contracts between the Company or any subsidiary of the Company on the one hand,
and on the other hand, any of its related parties, as defined in the Company's policy that regulates this matter, in amounts greater than
R$ 20,000 .000.00 30,000,000.00(twenty
thirty million reais) per operation or higher, together, to R$ 60,000,000.00 90,000,000.00(sixty
ninety million reais) per fiscal year, considering that this refers to the set of related transactions,
pursuant to the definition of related transactions provided in CVM Resolution No. 80/22; |
| (xix) | setting annual limits per transaction within which the Directors may, in accordance with the terms of
Article 37, without prior authorization from the Board of Directors, contract loans, financing or capital market transactions whose applicable
laws or regulations do not require authorization by the Board or the General Meeting, whether in Brazil or elsewhere; |
| (xx) | to approve the acquisition of raw materials, by the Company or any of its subsidiaries, in an annual value
greater than the equivalent amount in Reais of US $ 350,000,000.00 (three hundred and fifty million dollars), by contract or sequence
of similar contracts within of the same operation, considering the period of 12 (twelve) months from the first contract, observing that
the acquisitions of raw material with related parties must follow the rule provided for in item “xviii”; |
| (xxi) | deciding on the granting or guarantees by the Company or its controlled companies for any value related
to obligations assumed by third parties that are not controlled companies of the Company; |
| (xxii) | deliberating, within the limits of the Authorized Capital, on the issue of shares and subscription warrants
by the Company, as well as of promissory notes for public distribution (“commercial paper”); |
| (xxiii) | approving the program for repurchase of shares of the Company or any of its publicly-held controlled company
to be held in treasury or to be cancelled, as well as the subsequent divestment or cancellation of the respective shares, in accordance
with the terms of the law and the rules published by the Brazilian Securities Commission; |
| (xxiv) | approving the issue of debentures convertible into shares within the limit of the Authorized Capital,
and the issue of debentures not convertible into shares; |
| (xxv) | approving the granting by the Company to its administrators employees, or individuals providing services
to the Company or a company under its control, of stock options within the limit of its Authorized Capital and according to a plan approved
by the General Meeting; |
| (xxvi) | approving the creation or granting of options to buy or sell shares by the Company and/or its controlled
companies and, in the case of the latter, provided such creation or granting does not result in the admission of a new shareholder (other
than one of its controlled companies) in such controlled company of the Company; |
| (xxvii) | approving the issue by the Company and its controlled companies of promissory notes regulated by the Brazilian
Securities Commission; |
| (xxviii) | instructing the representatives of the Company and its controlled companies regarding the exercise of
the voting right for the subjects set forth in (a) items i, ii, iii, vi, vii and xi; in such cases, provided it represents the admission
of a partner other than the Company and/or any of its controlled companies; (b) item v, when related to change of the corporate purpose;
and (c) items ix and xii, all from Article 17 hereof, always with the exception of operations and transactions already approved by the
Board of Directors; |
| (xxix) | deciding, within the limits of its authority, on cases not covered by these bylaws; and |
| (xxx) | authorizing the waiver of the right to subscribe for shares or debentures convertible into shares of subsidiaries,
controlled companies, provided it entails loss of control by the Company or associated companies and provided it results in an alteration
greater than five percent (5%) of the interest held by the Company; and |
| (xxxi) | to decide annually on the maintenance or adjustment by the IPCA index or another officially recognized
inflation index that may replace it, of the amounts and limits set forth in items II, XIV, XVII, XVIII, and XX of Article 26 of these
Bylaws. |
Article 278
The Chairman of the Board of Directors, in accordance with the
Operating Rules of the Board of Directors, will be responsible for the following actions:
a) calling and directing the meetings of the Board of Directors;
and
b) calling the General Meeting, subject to approval by the Board
of Directors.
Article 289
The Vice-Chairman, or in his/her absence, whoever is nominated
by the Chairman under the terms of Article 22, will be responsible for replacing the Chairman whenever the latter is absent or incapacitated
and, further, in the event of a vacancy, will occupy the position of Chairman until a new incumbent is elected.
CHAPTER VII
COMPLIANCE AND AUDIT
Article 3029
The Company will have a permanent Compliance and Audit Committee
set pursuant to the Bylaws, advisory body directly linked to the Board of Directors, composed of five (5) members elected by the Board
of Directors.
First Paragraph - The Compliance and Audit Committee set
pursuant to the Bylaws shall have in its composition (i) 3 (three) independent members of its Board of Directors pursuant to the Company's
own policy; and (ii) 2 (two) members who are not members of the Board of Directors, chosen in accordance with paragraph 2.
Second Paragraph - The 2 (two) non-participating members
of the Board of Directors shall be independent members, pursuant to CVM Resolution No. 23/21 or any other that may replace it, and shall
be chosen by the said body among those indicated in the list, to be submitted by the Chairman of the Board of Directors, drawn up by a
specialized company with proven experience, and the indication of names by shareholders is not allowed.
Third Paragraph - For the purposes of complying with CVM
Resolution No. 23/21, at least 1 (one) of the 3 (three) members of the Company's Board of Directors who are members of the Compliance
and Audit Committee set pursuant to the Bylaws must simultaneously meet the independence criteria provided for in the the Company's own
policy and the independence criteria provided for in CVM Resolution 23/21 or any other that may replace it.
Forth Paragraph - The members of the Compliance and Audit
Committee set pursuant to the Bylaws will be elected for a term of 02 (two) years and will hold their positions for a maximum of 10 (ten)
years.
Fifth Paragraph - For the members of the Compliance and
Audit Committee set pursuant to the Bylaws who are members of the Board of Directors, the resignation or removal of the position of member
of the Board of Directors will automatically result in the resignation or removal, as the case may be, of the position of member of the
Compliance and Audit
Committee set pursuant to the Bylaws.
Sixth Paragraph - At least one of the members of the Compliance
and Audit Committee set pursuant to the Bylaws must have recognized knowledge in the areas of corporate accounting, auditing and finance,
which characterizes him as a financial expert, pursuant to CVM Resolution No. 23/21 or any other that replace it, the US laws applicable
to the Company and listing rules to which the Company is subject, and the financial specialist may or may not be a member of the Board
of Directors.
Seventh Paragraph - The participation of Directors and employees
of the Company, its subsidiaries, parent company, affiliates or companies under common control, directly or indirectly, in the Compliance
and Audit Committee set pursuant to the Bylaws is prohibited.
Eighth Paragraph - The Compliance and Audit Committee set
pursuant to the Bylaws will have its own internal regulations approved by the Board of Directors which will describe in detail its functions,
as well as its operating procedures and attributions of its Coordinator.
Ninth Paragraph - The exercise of the activities of the
members of the Compliance and Audit Committee set pursuant to the Bylaws, as well as its internal regulations, shall comply with the rules
provided for in Brazilian regulations, especially in CVM Resolution 23/21, and in the United States, including the provisions of Sarbanes–Oxley
Act and in the rules issued by the Securities and Exchange Commission - SEC.
Tenth Paragraph - The same duties and responsibilities imposed
by law or by these Bylaws on the Company's managers shall apply to the members of the Compliance and Audit Committee set pursuant to the
Bylaws.
Article 310
The Company must maintain an area dedicated to the activities of
compliance, which will be led by an integral part of high hierarchy. Such member will report directly to the Compliance and Audit Committee
set pursuant to the Bylaws and said member will not be subordinated or connected to any other area or any other Officer of the Company,
and said member will have the powers required to ensure the fulfillment of his/her function in an independent manner.
CHAPTER VII
EXECUTIVE BOARD
Article 312
The Executive Board will consist of at least four (4) and at most
ten (10) individuals, with one Chief Executive Officer elected by the Board of
Directors and removable thereby at any time, observing the provisions
in the Shareholders’ Agreement filed at the Company’s headquarters.
Article 323
The Executive Board officers will have a term of office of three
(3) years..
Sole Paragraph - The Officers will take office by signing
the instruments of investiture drawn up in the Book of Minutes of the Executive Board’s Meetings, as well as the other documents
required by the applicable legislation and the Instrument of Consent of Administrators set forth in the Regulation, and the polices in
effect for the Company, and will remain in their positions with full exercise of their duties until their substitutes take office.
Article 334
In the absence or impairment of any Officer, the Chief Executive
Officer will be responsible for nominating, from among the other Officers, his/her substitute who shall accrue both duties, observing
the provisions of the Shareholders’ Agreement filed at the Company’s headquarters.
Sole Paragraph - In the absence or temporary impairment
of the Chief Executive Officer, the Chairman of the Board of Directors will be responsible for designating his/her substitute.
Article 345
In the event of a vacancy in the position of Officer, the Board
of Directors will be responsible for electing a substitute to hold the office for the remaining period of the term of office, observing
the provisions of the Shareholders’ Agreement filed at the Company’s headquarters.
Article 356
The Executive Board will be responsible for:
a) carrying out all actions necessary
for the functioning of the Company, except those that, by law or by these bylaws, are assigned to other bodies;
b) preparing the annual management
report, the financial statements and the proposal for allocation of income for the fiscal year, all of which will be submitted to the
Board of Directors and the General Meeting;
Article 367
The Chief Executive Officer will be responsible for:
a) proposing the overall organizational
macrostructure of the Company to the Board of Directors;
b) defining the areas of authority
and coordinating the actions of the Officers in implementing the Company’s Business Plan;
c) calling and presiding over
meetings of the Executive Board;
d) submitting the Business Plan to approval by the Board of Directors;
and
e) proposing polices to the Board of Directors for general application
in the Company.
Article 378
The remaining Officers will be responsible for carrying out actions
and managing within the attributions defined in the basic management structure.
Sole Paragraph – Without prejudice to the provisions
of Article 39 hereof, any two (2) Officers shall represent the Company as either plaintiff or defendant, in or out of court.
Article 389
The Company may nominate attorneys-in-fact and the relevant document
must be signed by two members of the Executive Board.
Sole Paragraph - The powers of attorney must specify
the powers granted and the duration of the term office, which shall be limited to a maximum of one (1) year, except for those granted
for representation of the Company in legal or administrative proceedings or which the exercise thereof until the conclusion of the issue
or proceeding is essential to the term of office.
Article 3940
Except for the cases established in these Bylaws, the Company will
only be bound by documents signed jointly by:
a) 2 (two) Officer; or
b) 1 (one) Officer and one Attorney-in-Fact, or 2 (two) Attorneys-in-Fact
with specific powers granted in accordance with Article 38 of these Bylaws.
First Paragraph - The following acts may only be signed
by 1 (one) Officer, or by 1 (one) Attorney-in Fact, appointed according to these Bylaws:
a) the endorsement of checks and money orders for deposit in the
Company’s bank account;
b) authorizations to make transactions in the blocked account of
the Unemployment Compensation Fund (FGTS);
c) the registration and issue of documents regarding to labor,
tax and customs and digital certification related matters; and
d) the receipt of any amounts due by signing the receipts and giving
release.
Second Paragraph - In special cases, express powers may
be granted to only one Officer or Attorney-in-Fact in order to carry out acts specified in the relevant documents, with due regard to
the rule set forth in the Article 38 of these Bylaws.
Article 401
The Executive Board will meet when summoned by the Chief Executive
Officer.
Sole Paragraph - The Executive Board may meet with at least
half of its current members in attendance, with the Chief Executive Officer or his/her alternate included among them, in accordance with
Article 33, Sole Paragraph.
Article 412
The Executive Board is prohibited from:
a) taking out loans with institutions that are not members of the
official or private banking network, whether within Brazil or abroad, unless expressly authorized by the Board of Directors;
b) performing acts of any nature relating to business or operations
that are not consistent with the Company’s objectives, such as the provision of guarantees on third-party liabilities, except to
controlled companies, or if expressly authorized by the Board of Directors.
CHAPTER IX
FISCAL BOARD
Article 423
The Fiscal Board, composed of up to five (5) members and their
alternates, elected by the General Meeting, pursuant to the provisions of the Shareholders’ Agreements filed at the Company’s
headquarters shall operate on a permanent basis, in accordance with the Law.
Sole Paragraph - The holders of non-voting preferred shares
or with restricted voting rights, will be entitled to elect one member and his/her respective alternate. Minority shareholders will be
assured the same right,
provided that they jointly represent ten per cent (10%) or more
of the voting shares.
Article 434
The Fiscal Board will be effective for one (1) year, re-election
permitted, and the election shall always take place during the Annual General Meeting.
First Paragraph – The members of the Fiscal Board
will be invested in office upon the execution of deeds of investiture drawn-up in the Book of Minutes of the Fiscal Board Meetings, as
well as the other documents required by the applicable legislation and the instrument of consent and/or adhesion to the polices in effect
at the Company, remaining in their posts with full exercise of their duties until their substitutes take office.
Second Paragraph – In the event of a vacancy in the
position of Director, the substitute shall automatically become its respective alternate in case no other Member is appointed by the remaining
Directors form among the substitutes Directors, pursuant to the provision of the Shareholders’ Agreements filed at the Company’s
headquarters, and shall act until the first General Meeting in which its name may be ratified or replaced by the shareholders. The substitute
elected to fill the vacant position shall complete the remaining management term of the replaced member.
Third Paragraph – The Fiscal Board shall adopt its
own Set of Rules, which will establish procedures regarding its duties.
Article 445
The members of the Audit Committee will receive the compensation
established by the Meeting that elects them, observing the relevant terms of the law.
CHAPTER X
FINANCIAL YEAR, FINANCIAL STATEMENTS AND
DISTRIBUTION OF PROFITS
Article 456
The financial year begins on January 1 and ends on December 31
of each year.
Article 467
At the end of each financial year, the Company’s financial
statements will be prepared on the basis of the Company’s official accounting records, as established by law.
First Paragraph - Profit sharing eventually attributable
to the Company’s officers will be deducted from the net income for the financial year, after absorption of accumulated losses and
deductions for the provision for income tax pursuant to the decision of the Annual General Meeting, observing the legal limits on the
same, the AGM only approving the distribution of such profit sharing after the minimum dividends established in Article 9, item “c”
of these bylaws have been guaranteed to the voting shares.
Second Paragraph - Of the net income verified in accordance
with the Law, five per cent (5%) will be deducted for the constitution of a Legal Reserve Fund, until this reaches an amount equivalent
to twenty per cent (20%) of the capital stock.
Third Paragraph - Shareholders will be entitled to receive
a mandatory dividend of twenty five per cent (25%) of the net income for the financial year, determined at the end of each financial year
according to the terms of the law pursuant to the legal and statutory rights of the preferred shares. When the value of the preferential
dividend paid to the preferred shares is equal to or greater than 25% of the net income for the financial year, calculated in accordance
with Article 202 of Law No 6,404/76, this will be considered to represent payment in full of the obligatory dividend. If there is any
residual mandatory dividend after the payment of the preferential dividend, it will be assigned:
a) in the form of a payment to
the common shares of a dividend up to the limit of the preferential dividend of the preferred shares; and
b) in the event of a continued
residual balance, in the distribution of an additional dividend to the common and the class “A” preferred shares on an equal
basis, in such a way that each voting or preferred share of that class receives the same dividend.
Fourth Paragraph - The Company, may, at its discretion,
draw up quarterly and/or half-yearly financial statements. If there is positive net income in such statements, dividends may be distributed
in accordance with the terms of the law, by prior decision of the Board of Directors, ad referendum of the General Meeting.
Fifth Paragraph - The Board of Directors may declare interim
dividends using profit reserves held over from previous annual or half-yearly balance sheets.
Sixth Paragraph - The Company may, at the decision of the
Board of Directors, pay interest on capital to its shareholders in accordance with the terms of Article 9, Paragraph 7 of Law No. 9,249
of December 26, 1995 and relevant legislation, offsetting the amount of interest paid or credited
against the value of the preferential dividend for the preferred
shares and the mandatory dividend established in Article 9 and the third paragraph of Article 46 of these bylaws, respectively.
Article 478
The dividends and the interest on capital considered in the sixth
paragraph of Article 46 that is attributed to the shareholders will not be subject to interest, and if not claimed within three (3) years
of the initial date for payment of each dividend or payment of interest on capital, will revert to the Company.
CHAPTER XI
SHAREHOLDERS AGREEMENT
Article 489
The Shareholders Agreements duly registered at the Company’s
headquarters, which, among other things, establish clauses and conditions for the purchase and sale of shares issued by the Company, preemptive
rights in acquiring the same, exercising voting rights or power of control, will be respected by the Company, by Management and by the
Chairman of the General Meetings.
Sole Paragraph - The obligations and responsibilities arising
from such agreements will be valid and will be binding on third parties as soon as such agreements have been registered in the Company’s
books. Company management will ensure that these agreements are respected and the Chairman of the General Meeting or the Chairman of the
Meetings of the Board of Directors will, as the case may be, act in accordance with the terms established in law.
CHAPTER XII
GENERAL CONSIDERATIONS
Article 4950
The Company shall be liquidated pursuant to the terms of the Law.
Sole Paragraph - In the event of the extrajudicial liquidation
of the Company, it shall be incumbent on the General Meeting to determine the manner of liquidation, appoint the liquidator and the Audit
Committee that will function during the liquidation period.
Article 501
The amounts in US dollars mentioned in these Bylaws shall be used
exclusively as a reference for the range of values and shall be considered by their equivalent values in Reais, converted by the average
exchange rate disclosed by the Central Bank of Brazil, considering for this purpose the average of the month prior to the operation.
Consolidation - 11/30/2004
Amendment on 03/31/2005 - Article 4 – Reverse Shares Split
Amendment on 05/31/2006 - Article 4 - Capital Stock – Incorporation
of Polialden
Amendment on 04/02/2007 - Article 4 - Capital Stock – Incorporation
of Politeno
Amendment on 07/31/2007 - Article 4 - Capital Stock – Board
of Directors Meeting No. 530
Amendment on 3/6/2008 - Article 4 - Capital Stock – Extraordinary
General Meeting (EGM)
Amendment on 05/30/2008 - Article 4 – Capital Stock - EGM
– Incorporation of Grust
Amendment on 09/30/2008 - Article 4 – Capital Stock - EGM
– Incorporation of IPQ
Amendment on 12/22/2008 - Article 4 - Cancellation of Shares
Amendment on 04/30/2009 - Article 4 and Paragraph 1 - Capital Stock
– Incorporation of P. Triunfo
Amendment on 02/25/2010 - Article 4, Paragraph 1 - Limit of Authorized
Capital
Amendment on 12/27/2010 - Article 4 - Capital Stock – Incorporation
of Quattor Petroquímica Reform and Consolidation - 02/28/2012
Amendment on 04/12/2012 - Article 4 - Capital Stock - EGM - Cancellation
of Shares
Amendment and Consolidation - 04/16/2016 - Article 4 - Conversion
of class "B" preferred shares into class "A" preferred shares
Amendment on 11/30/2017 - Article 2, inclusion of the activities
that were developed by Braskem Petroquímica Ltda. and had no equivalent in the Company's corporate purpose; Article 4, Conversion
of class "B" preferred shares into class "A" preferred share; and Article 39, Rectification of letter "b"
for conceptual alignment with item "xx" of Article 26.
Amendment on 04/30/2018 - Article 4, Conversion of class "B"
preferred shares into class "A" preferred shares; Article 18, Insertion of paragraphs 1, 2 and 3 to provide for a minimum percentage
of 20% of independent members of the Company's Board of Directors; and New Chapter VII, providing for the creation of a permanent Compliance
Committee and the formalization of the existence of a Compliance area in the Company.
Amendment on 10/16/2018 – Article 4th, conversion of class
“B” preferred shares into class “A”; Article 26, item “xviii”, in order to exclude the exception to
raw material contracts under the competence of the Board of Directors that deals with contracting with related parties, include reference
to the company policy that regulates the matter, as well as to increase the limit values for approval. Consolidation on 08/24/2020 –
Consolidation of the amendments to the Bylaws approved at the Company's General Meetings of November 30, 2017, April 30, 2018 and
October 16, 2018, since such meetings did not formalize the consolidation
of the Company's Bylaws.
Amendment on 04/13/2021 - Article 1, paragraph 1 to change the corporate
name of B3 S.A. - Brasil, Bolsa Balcão; Article 17, (xi) for cross-reference adjustment; Article 26 (xx) for inclusion of item
to regulate the competence of the Board of Directors to deliberate on the acquisition of raw materials; Article 26 (xxv) for wording adjustment;
Creation of Article 50 to provide for the applicable rules for converting the limit for the acquisition of raw materials foreseen in dollars
to the equivalent in reais.
Amendment on 07/30/2021 - Articles 29 and 30, transformation of
the Compliance Committee into the Compliance and Audit Committee set pursuant to the Bylaws.
Amendment on 04/19/2022 - Article 4, conversion of class "B"
preferred shares into class "A" preferred shares
Amendment on 11/13/2025 – Article 2 to detail
the list of the Company's objectives, aligning the corporate purpose with the current reality and activities performed by the Company;
inclusion of Article 20 to specify the rules and procedures for the election of the Board of Directors at the General Shareholders’
Meeting; Article 27 to update the approval thresholds of the Board of Directors based on inflation since the last update (IPCA), and to
include a provision authorizing the Board of Directors to annually decide on the maintenance or monetary adjustment of such thresholds,
in addition to removing from the Board of Directors’ responsibilities the selection and replacement of independent auditors of the
Company’s subsidiaries.
* * *
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
Date: October 13, 2025
|
BRASKEM S.A. |
|
|
|
|
|
|
|
|
|
By: |
/s/ Felipe Montoro Jens |
|
|
|
|
|
Name: |
Felipe Montoro Jens |
|
|
Title: |
Chief Financial Officer |
DISCLAIMER
ON FORWARD-LOOKING STATEMENTS
This
report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.
These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future
economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected
impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating
results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans”
and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the
potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital
expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results
of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject
to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events,
trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market
conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of
the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees,
service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations.
Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings
made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of
the risks and other factors that may impact any forward-looking statements in this presentation.